Omeprazole or Ranitidine Plus Metoclopramide for Patients with Severe Erosive Oesophagitis

[1]  B. Bloom.  Cost and Quality Effects of Treating Erosive Oesophagitis , 1995, PharmacoEconomics.

[2]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[3]  A. McCullough,et al.  Omeprazole is superior to ranitidine plus metoclopramide in the short‐term treatment of erosive oesophagitis , 1993, Alimentary pharmacology & therapeutics.

[4]  B. Bloom,et al.  Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease. , 1992, Archives of internal medicine.

[5]  R S Woodward,et al.  The effect of prescribed daily dose frequency on patient medication compliance. , 1990, Archives of internal medicine.

[6]  J. Dent,et al.  Healing and relapse of severe peptic esophagitis after treatment with omeprazole. , 1988, Gastroenterology.

[7]  L. Lundell,et al.  Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. , 1988, Scandinavian journal of gastroenterology.

[8]  G. Vantrappen,et al.  Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis , 1988, Digestive Diseases and Sciences.

[9]  C. Fenger,et al.  Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial , 1988, British medical journal.

[10]  P. Zeitoun,et al.  OMEPRAZOLE VERSUS RANITIDINE IN EROSIVE OESOPHAGITIS , 1987, The Lancet.

[11]  J. Jansen,et al.  DOUBLE-BLIND MULTICENTRE COMPARISON OF OMEPRAZOLE AND RANITIDINE IN THE TREATMENT OF REFLUX OESOPHAGITIS , 1987, The Lancet.

[12]  A. Blum,et al.  Comparison of omeprazole and ranitidine in the treatment of reflux esophagitis. , 1986, The New England journal of medicine.

[13]  Igor Sartori,et al.  Empirical Evidence of Bias. Dimensions of Methodological Quality Associated with Estimates of Treatment Effects in Controlled Trials , 1996 .

[14]  A. Ippoliti,et al.  Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter Study. , 1992, Gastroenterology.